The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Mucus as a Barrier to Drug Delivery – Understanding and Mimicking the Barrier Properties
Abstract
Viscoelastic mucus lines all mucosal surfaces of the body and forms a potential barrier to mucosal drug delivery. Mucus is mainly composed of water and mucins; high molecular weight glycoproteins forming an entangled network. Consequently, mucus forms a steric barrier, and due to its negative charge and hydrophobic domains, the overall hydrophilic mucus also presents an interactive barrier limiting the free diffusion of components within and through the mucus. Furthermore, mucus is a dynamic barrier due to its continuous secretion and shedding from the mucosal surfaces. Mucus is thus a highly complex gel barrier to drug delivery. Current knowledge of mucus characteristics and barrier properties, as achieved by state‐of‐the‐art methodologies, is the topic of this MiniReview emphasizing the gastrointestinal mucus and an overall focus on oral drug delivery. Cell culture‐based in vitro models are well‐established as essential tools in drug research and development, but traditionally, mucus‐containing models have only rarely been applied. However, a number of mucus‐containing in vitro models have recently been described in the literature, and their properties and applications will be reviewed and discussed. Finally, studies of peptide and protein drug diffusion in and through mucus and studies of mucus‐penetrating nanoparticles are included to illustrate the mucus as a potentially important barrier to obtain sufficient bioavailability of orally administered drugs, and thus an important parameter to address in the development of future oral drug delivery systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Lai, S. K., Wang, Y.-Y., & Hanes, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.002 · Cited by 1,815
Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers
Ensign, L. M., Cone, R., & Hanes, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.009 · Cited by 1,623
Kararli, T. T. (1995) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2510160502 · Cited by 1,459
Cone, R. A. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.008 · Cited by 1,459
The gastrointestinal mucus system in health and disease
Johansson, M. E. V., Sjövall, H., & Hansson, G. C. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.35 · Cited by 1,438
Protein drug stability: a formulation challenge
Frokjaer, S., & Otzen, D. E. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1695 · Cited by 1,096
The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo
Atuma, C., Strugala, V., Allen, A., & Holm, L. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.280.5.g922 · Cited by 1,078
Wang, Y., Lai, S. K., Suk, J. S., Pace, A., Cone, R., & Hanes, J. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200803526 · Cited by 597
Challenges for the oral delivery of macromolecules
Goldberg, M., & Gomez-Orellana, I. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1067 · Cited by 544
Diffusion of Macromolecules and Virus-Like Particles in Human Cervical Mucus
Olmsted, S. S., Padgett, J. L., Yudin, A. I., Whaley, K. J., Moench, T. R., & Cone, R. A. (2001) · Biophysical Journal · doi:10.1016/s0006-3495(01)75844-4 · Cited by 544
Perspectives on the significance of altered glycosylation of glycoproteins in cancer
Kim, Y. J., & Varki, A. (1997) · Glycoconjugate Journal · doi:10.1023/a:1018580324971 · Cited by 535
Nanoparticle diffusion in respiratory mucus from humans without lung disease
Schuster, B. S., Suk, J. S., Woodworth, G. F., & Hanes, J. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.064 · Cited by 461
Grainger, C. I., Greenwell, L. L., Lockley, D. J., Martin, G. P., & Forbes, B. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0255-0 · Cited by 388
Biological hydrogels as selective diffusion barriers
Lieleg, O., & Ribbeck, K. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.06.002 · Cited by 387
Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses
Lai, S. K., Wang, Y.-Y., Hida, K., Cone, R., & Hanes, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911748107 · Cited by 384
Human colonic adenocarcinoma cells: I. Establishment and description of a new line
Tom, B. H., Rutzky, L. P., Jakstys, M. M., Oyasu, R., Kaye, C. I., & Kahan, B. D. (1976) · In Vitro · doi:10.1007/bf02796440 · Cited by 378
Rheology of Gastric Mucin Exhibits a pH-Dependent Sol−Gel Transition
Celli, J. P., Turner, B. S., Afdhal, N. H., Ewoldt, R. H., McKinley, G. H., Bansil, R., & Erramilli, S. (2007) · Biomacromolecules · doi:10.1021/bm0609691 · Cited by 310
Barrier Properties of Gastrointestinal Mucus to Nanoparticle Transport
Crater, J. S., & Carrier, R. L. (2010) · Macromolecular Bioscience · doi:10.1002/mabi.201000137 · Cited by 302
Mucus Penetrating Nanoparticles: Biophysical Tool and Method of Drug and Gene Delivery
Ensign, L. M., Schneider, C., Suk, J. S., Cone, R., & Hanes, J. (2012) · Advanced Materials · doi:10.1002/adma.201201800 · Cited by 290
Mucus as a barrier to lipophilic drugs
Sigurdsson, H. H., Kirch, J., & Lehr, C.-M. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.05.040 · Cited by 280
Lesuffleur, T., Porchet, N., Aubert, J.-P., Swallow, D., Gum, J. R., Kim, Y. S., & Real, F. X. (1993) · Journal of Cell Science · doi:10.1242/jcs.106.3.771 · Cited by 277
Antunes, F., Andrade, F., Araújo, F., Ferreira, D., & Sarmento, B. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.10.003 · Cited by 269
pH-Dependent Conformational Change of Gastric Mucin Leads to Sol-Gel Transition
Cao, X., Bansil, R., Bhaskar, K. R., Turner, B. S., LaMont, J. T., Niu, N., & Afdhal, N. H. (1999) · Biophysical Journal · doi:10.1016/s0006-3495(99)77288-7 · Cited by 229
Kirch, J., Schneider, A., Abou, B., Hopf, A., Schaefer, U. F., Schneider, M., Schall, C., Wagner, C., & Lehr, C.-M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214066109 · Cited by 190
Friedl, H., Dünnhaupt, S., Hintzen, F., Waldner, C., Parikh, S., Pearson, J. P., Wilcox, M. D., & Bernkop-Schnürch, A. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23757 · Cited by 180
Comparative rheological investigation of crude gastric mucin and natural gastric mucus
Kočevar-Nared, J., Kristl, J., & Šmid-Korbar, J. (1997) · Biomaterials · doi:10.1016/s0142-9612(96)00180-9 · Cited by 177
The Influence of Intestinal Mucus Components on the Diffusion of Drugs
Larhed, A. W., Artursson, P., & Björk, E. (1998) · Pharmaceutical Research · doi:10.1023/a:1011948703571 · Cited by 165
Spatial Configuration and Composition of Charge Modulates Transport into a Mucin Hydrogel Barrier
Li, L. D., Crouzier, T., Sarkar, A., Dunphy, L., Han, J., & Ribbeck, K. (2013) · Biophysical Journal · doi:10.1016/j.bpj.2013.07.050 · Cited by 159
Navabi, N., McGuckin, M. A., & Lindén, S. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068761 · Cited by 159
Atomic Force Microscopy Reveals Aggregation of Gastric Mucin at Low pH
Hong, Z., Chasan, B., Bansil, R., Turner, B. S., Bhaskar, K. R., & Afdhal, N. H. (2005) · Biomacromolecules · doi:10.1021/bm0505843 · Cited by 147
Boegh, M., Baldursdóttir, S., Müllertz, A., & Nielsen, H. M. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.01.001 · Cited by 141
Self-citationZabaleta, V., Ponchel, G., Salman, H. H., Agüeros, M., Vauthier, C., & Irache, J. M. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.04.001 · Cited by 123
Forier, K., Messiaen, A.-S., Raemdonck, K., Deschout, H. G., Rejman, J., Baets, F. D., Nelis, H. J. C. F., Smedt, S. C. D., Demeester, J., Coenye, T., et al. (2012) · Nanomedicine · doi:10.2217/nnm.12.129 · Cited by 119
Teubl, B. J., Absenger, M., Fröhlich, E., Leitinger, G., Zimmer, A., & Roblegg, E. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.10.021 · Cited by 111
Ensign, L. M., Henning, A., Schneider, C. S., Maisel, K., Wang, Y.-Y., Porosoff, M. D., Cone, R. A., & Hanes, J. S. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400087y · Cited by 105
Mucin layers and multilayers — Physicochemical properties and applications
Svensson, O., & Arnebrant, T. (2010) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2010.05.015 · Cited by 96
Fate of paclitaxel lipid nanocapsules in intestinal mucus in view of their oral delivery
Lagarce, F., Groo, A., Saulnier, P., Gimel, J.-C., Gravier, J., Ailhas, C., & Benoît, J. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s51837 · Cited by 96
Mucus thickness in the gastrointestinal tract of laboratory animals
Varum, F., Veiga, F., Sousa, J., & Basit, A. W. (2011) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2011.01399.x · Cited by 81
Wang, Y.-Y., Lai, S. K., Ensign, L. M., Zhong, W., Cone, R. A., & Hanes, J. S. (2013) · Biomacromolecules · doi:10.1021/bm401356q · Cited by 63
Novel engineered systems for oral, mucosal and transdermal drug delivery
Li, H., Yu, Y., Dana, S. F., Li, B., Lee, C., & Kang, L. (2013) · Journal of drug targeting · doi:10.3109/1061186x.2013.805335 · Cited by 60
Mucosal drug delivery: barriers, in vitro models and formulation strategies
Boegh, M., Foged, C., Müllertz, A., & Nielsen, H. M. (2013) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(13)50055-4 · Cited by 56
Self-citationFunctional Morphology of the Gastrointestinal Tract
Shen, L. (2009) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-01846-6_1 · Cited by 53
Groo, A., Mircheva, K. M., Bejaud, J., Ailhas, C., Panaiotov, I., Saulnier, P., Ivanova, T., & Lagarce, F. (2014) · Pharmaceutical Research · doi:10.1007/s11095-013-1280-4 · Cited by 51
Adherent surface mucus gel restricts diffusion of macromolecules in rat duodenum in vivo
Flemström, G., Hällgren, A., Nylander, O., et al. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.277.2.g375 · Cited by 42
Round, A. N., McMaster, T. J., Miles, M. J., Corfield, A. P., & Berry, M. (2007) · Glycobiology · doi:10.1093/glycob/cwm027 · Cited by 24
Cited by
Gänger, S., & Schindowski, K. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030116 · Cited by 447
Engineering nano-drug biointerface to overcome biological barriers toward precision drug delivery
Waheed, S., Li, Z., Zhang, F., Chiarini, A., Armato, U., & Wu, J. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01605-4 · Cited by 259
Drug permeability profiling using cell-free permeation tools: overview and applications
Berben, P., Bauer-Brandl, A., Brandl, M., Faller, B., Flaten, G. E., Jacobsen, A.-C., Brouwers, J., & Augustijns, P. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.04.016 · Cited by 199
Verma, S., Goand, U. K., Husain, A., Katekar, R. A., Garg, R., & Gayen, J. R. (2021) · Drug Development Research · doi:10.1002/ddr.21832 · Cited by 151
Oral lipid nanomedicines: Current status and future perspectives in cancer treatment
El Moukhtari, S. H., Rodríguez-Nogales, C., & Blanco-Prieto, M. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.03.004 · Cited by 70
Metadata
- Authors
- Boegh, M., & Nielsen, H. M.
- Venue
- Basic & Clinical Pharmacology & Toxicology
- Publisher
- Wiley
- Published
- 2014-12-23
- Volume
- 116
- Issue
- 3
- Pages
- 179-186
- ISSN
- 1742-7835 (ISSN-L)
- 1742-7843
- OpenAlex
- W2068820688
- Cited by
- 384
- References
- 45
- FWCI
- 5.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
